Skip to main content
. 2017 May 19;60(8):1390–1399. doi: 10.1007/s00125-017-4289-0

Fig. 2.

Fig. 2

Geometric mean insulin response to an IVGTT in participants with type 2 diabetes before and after 12 weeks of treatment with semaglutide (n = 37, dark blue) or placebo (n = 37, light blue). One participant who received an incorrect glucose dose was excluded from all IVGTT analyses. Dotted lines represent baseline values and solid lines represent end of treatment values